Search Within

Joachim Yahalom

Formats
  1. Journal Article (283)
  2. Meeting Abstract (250)
  3. Book Section (67)
  4. Review (9)
  5. Conference Paper (6)
  6. Research Letter (6)
  7. Guidelines (5)
  8. Correspondence (4)
  9. Editorial (3)
  10. Book Whole (1)
Groups
  1. Radiation Oncology, Department of (634)
  2. Survivorship Research (634)
  3. Department of Medicine (290)
  4. Hematologic Malignancies, Division of (284)
  5. Center for Hematologic Malignancies (254)
  6. Lymphoma (210)

More Groups

People
  1. Brandon Imber (122)
  2. Andrew Zelenetz (119)
  3. Craig Moskowitz (87)
  4. David Straus (82)
  5. Ariela Noy (74)
  6. Carla Hajj (74)

More People

Years
  1. 2025 (11)
  2. 2024 (33)
  3. 2023 (48)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (24)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (126)
  2. Blood (103)
  3. Journal of Clinical Oncology (46)
  4. Hematological Oncology (34)
  5. Journal of the National Comprehensive Cancer Network (31)
  6. Leukemia and Lymphoma (17)

More Publications

Publishers
  1. Elsevier Inc. (162)
  2. American Society of Hematology (113)
  3. American Society of Clinical Oncology (46)
  4. Wiley Blackwell (43)
  5. Harborside Press (31)
  6. Lippincott Williams & Wilkins (28)

More Publishers

Results (634)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal
    Review

    Cederquist, G. Y.; Tringale, K.; Yahalom, J.; Imber, B. S.
    Seminars in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • CTEP 10590, NORM: Nodular lymphocyte predominant Hodgkin lymphoma patients treated in a randomized phase II trial with either rituximab or mosunetuzumab
    Meeting Abstract

    Steiner, R.; Bock, A. M.; Herrera, A. F.; Zulfa, O.; Hoffmann, M.; Ibrahimi, S.; Galanina, N.; Lee, H. J.; Green, M.; Lin, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Bridging radiotherapy may decrease inflammation prior to CAR-T cell therapy
    Meeting Abstract

    Patel, R. R.; Tward, A.; Fregonese, B.; Hubbeling, H.; Lapen, K.; Mankuzhy, N. P.; Raj, S. S.; Perales, M. A.; Shouval, R.; Yahalom, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improved outcomes for primary refractory classical Hodgkin Lymphoma: A retrospective analysis
    Meeting Abstract

    Santarosa, A. M.; Ganesan, N.; Chang, T.; Hannigan, K.; Casper, E.; Shah, G. L.; Boardman, A. P.; Caron, P.; David, K. A.; Dogan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A Proof-of-principle of split-course bridging radiotherapy (SC-BRT) prior to CAR T-cell therapies for relapsed or refractory B-cell lymphomas: A phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K. K.; Boardman, A. P.; Dahi, P. B.; Shah, G. L.; Scordo, M.; Park, J. H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Very low dose radiotherapy (VLDRT) with 4 Gy for potentially-curable indolent non-Hodgkin lymphomas
    Meeting Abstract

    Mankuzhy, N. P.; Imber, B. S.; Pammer, P.; Fregonese, B.; Cajo, A.; Cederquist, G.; Dreyfuss, A.; Lapen, K.; Patel, R. R.; Moore, Z. R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab maintenance instead of autologous hematopoietic cell transplantation for patients with relapsed or refractory Hodgkin lymphoma in complete response after pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin
    Meeting Abstract

    Moskowitz, A.; Shah, G. L.; Ganesan, N.; Chang, T.; Drill, E.; Davey, T.; Hancock, H.; Munayirji, B.; Douglas, M.; Santarosa, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The art of war: Using genetic insights to understand and harness radiation sensitivity in hematologic malignancies
    Review

    Wijetunga, N. A.; Yahalom, J.; Imber, B. S.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Primary central nervous system lymphoma
    Book Section

    Imber, B. S.; Tringale, K. R.; Milgrom, S. A.; Yahalom, J.
    In Chang, E. L.; Lo, S. S.; Suh, J. H.; Brown, P. D.; Sahgal, A. (Eds.) Adult CNS Radiation Oncology: Principles and Practice. 2nd ed (2024)

    Fulltext@MSK | Save